株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ウイルスクリアランスの世界市場

Viral Clearance

発行 Global Industry Analysts, Inc. 商品コード 893765
出版日 ページ情報 英文 107 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
ウイルスクリアランスの世界市場 Viral Clearance
出版日: 2019年10月01日 ページ情報: 英文 107 Pages
概要

当レポートでは、世界のウイルスクリアランス (ウイルス除去) 市場について分析し、全体的な市場規模の実績値・予測値や、主な市場促進・抑制要因、用途別・エンドユース別および企業別の市場シェア動向 (過去9年間・今後8年間分)、今後の市場成長の方向性、各地域・主要国の市場の詳細動向などを調査すると共に、主要企業のプロファイルしております。

第1章 分析手法

第2章 エグゼクティブ・サマリー

  • 市場概要
    • 企業別の市場シェア構造 (最新値・予測値)
  • 代表的企業の分析
  • 市場の動向と促進要因
  • 世界市場の将来展望
    • 市場規模・シェアの動向見通し:地域別/国別
    • 遺伝子組み換えタンパク質
      • 市場規模 (過去9年間・今後8年間分)
      • 市場シェア:企業別 (通算17年間分)
    • 血液/血液製剤
    • ワクチン
    • その他の用途
    • 製薬企業/バイオテクノロジー企業
    • CRO (医薬品開発業務受託機関)
    • 教育・研究機関
    • その他のエンドユース

第3章 市場分析

  • 地域別の市場分析
    • 米国
      • 市場の基本データ
      • 企業別市場シェア
      • ウイルスクリアランスの市場規模 (実績値・予測値)
      • 用途別・エンドユース別の市場規模 (実績値・予測値)
    • カナダ
    • 日本
    • 中国
    • 欧州
      • フランス
      • ドイツ
      • イタリア
      • 英国
      • その他
    • アジア太平洋地域
    • 他の国々 (RoW)

第4章 企業

  • AVANCE BIOSCIENCES INC.
  • BSL BIOSERVICE SCIENTIFIC LABORATORIES MUNICH GMBH
  • CHARLES RIVER LABORATORIES INTERNATIONAL
  • CLEAN CELLS INC.
  • LONZA GROUP AG
  • MERCK KGAA
  • SGS SA
  • SIGMA-ALDRICH CORPORATION
  • TEXCELL, INC.

第5章 関連分析

目次
Product Code: MCP15504

Viral Clearance market worldwide is projected to grow by US$713.1 Million, driven by a compounded growth of 20.3%. Recombinant Proteins, one of the segments analyzed and sized in this study, displays the potential to grow at over 20.7%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$228.9 Million by the year 2025, Recombinant Proteins will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 22.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$23.7 Million to the region's size and clout in the next 5 to 6 years. Over US$32.9 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Recombinant Proteins will reach a market size of US$22.3 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 19.5% over the next couple of years and add approximately US$120.4 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Avance Biosciences Inc.; BSL BIOSERVICE Scientific Laboratories Munich GmbH; Charles River Laboratories International, Inc.; Clean Cells Inc.; Lonza Group AG; Merck KgaA; SGS SA; Sigma-Aldrich Corporation; Texcell, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Viral Clearance Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Viral Clearance Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
  • TABLE 2: Viral Clearance Market Share Shift across Key Geographies Worldwide: 2019 VS 2025
  • TABLE 3: Recombinant Proteins (Application) Global Opportunity Assessment in US$ Thousand by Region/Country: 2018-2025
  • TABLE 4: Recombinant Proteins (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2019 VS 2025
  • TABLE 5: Blood and Blood Products (Application) Worldwide Sales in US$ Thousand by Region/Country: 2018-2025
  • TABLE 6: Blood and Blood Products (Application) Market Share Shift across Key Geographies: 2019 VS 2025
  • TABLE 7: Vaccines (Application) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2018-2025
  • TABLE 8: Vaccines (Application) Market Share Breakdown by Region/Country: 2019 VS 2025
  • TABLE 9: Other Applications (Application) Demand Potential Worldwide in US$ Thousand by Region/Country: 2018-2025
  • TABLE 10: Other Applications (Application) Share Breakdown Review by Region/Country: 2019 VS 2025
  • TABLE 11: Pharmaceutical & Biotechnology (End-Use) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2018-2025
  • TABLE 12: Pharmaceutical & Biotechnology (End-Use) Distribution of Global Sales by Region/Country: 2019 VS 2025
  • TABLE 13: CROs (End-Use) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2018 through 2025
  • TABLE 14: CROs (End-Use) Global Market Share Distribution by Region/Country for 2019 and 2025
  • TABLE 15: Academic Research Institutes (End-Use) Global Opportunity Assessment in US$ Thousand by Region/Country: 2018-2025
  • TABLE 16: Academic Research Institutes (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2019 VS 2025
  • TABLE 17: Other End-Uses (End-Use) Worldwide Sales in US$ Thousand by Region/Country: 2018-2025
  • TABLE 18: Other End-Uses (End-Use) Market Share Shift across Key Geographies: 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Viral Clearance Market Share (in %) by Company: 2019 & 2025
    • TABLE 19: United States Viral Clearance Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025
    • TABLE 20: Viral Clearance Market Share Breakdown in the United States by Application: 2019 VS 2025
    • TABLE 21: United States Viral Clearance Latent Demand Forecasts in US$ Thousand by End-Use: 2018 to 2025
    • TABLE 22: Viral Clearance Market Share Breakdown in the United States by End-Use: 2019 VS 2025
  • CANADA
    • TABLE 23: Canadian Viral Clearance Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025
    • TABLE 24: Canadian Viral Clearance Market Share Analysis by Application: 2019 VS 2025
    • TABLE 25: Canadian Viral Clearance Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2018 to 2025
    • TABLE 26: Canadian Viral Clearance Market Share Analysis by End-Use: 2019 VS 2025
  • JAPAN
    • TABLE 27: Japanese Demand Estimates and Forecasts for Viral Clearance in US$ Thousand by Application: 2018 to 2025
    • TABLE 28: Viral Clearance Market Share Shift in Japan by Application: 2019 VS 2025
    • TABLE 29: Japanese Demand Estimates and Forecasts for Viral Clearance in US$ Thousand by End-Use: 2018 to 2025
    • TABLE 30: Viral Clearance Market Share Shift in Japan by End-Use: 2019 VS 2025
  • CHINA
    • TABLE 31: Chinese Demand for Viral Clearance in US$ Thousand by Application: 2018 to 2025
    • TABLE 32: Chinese Viral Clearance Market Share Breakdown by Application: 2019 VS 2025
    • TABLE 33: Chinese Demand for Viral Clearance in US$ Thousand by End-Use: 2018 to 2025
    • TABLE 34: Chinese Viral Clearance Market Share Breakdown by End-Use: 2019 VS 2025
  • EUROPE
    • Market Facts & Figures
    • European Viral Clearance Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 35: European Viral Clearance Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
    • TABLE 36: European Viral Clearance Market Share Shift by Region/Country: 2019 VS 2025
    • TABLE 37: European Viral Clearance Addressable Market Opportunity in US$ Thousand by Application: 2018-2025
    • TABLE 38: European Viral Clearance Market Share Analysis by Application: 2019 VS 2025
    • TABLE 39: European Viral Clearance Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025
    • TABLE 40: European Viral Clearance Market Share Analysis by End-Use: 2019 VS 2025
  • FRANCE
    • TABLE 41: Viral Clearance Quantitative Demand Analysis in France in US$ Thousand by Application: 2018-2025
    • TABLE 42: French Viral Clearance Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025
    • TABLE 43: Viral Clearance Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2018-2025
    • TABLE 44: French Viral Clearance Market Share Analysis: A 7-Year Perspective by End-Use for 2019 and 2025
  • GERMANY
    • TABLE 45: Viral Clearance Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025
    • TABLE 46: Viral Clearance Market Share Distribution in Germany by Application: 2019 VS 2025
    • TABLE 47: Viral Clearance Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2018-2025
    • TABLE 48: Viral Clearance Market Share Distribution in Germany by End-Use: 2019 VS 2025
  • ITALY
    • TABLE 49: Italian Demand for Viral Clearance in US$ Thousand by Application: 2018 to 2025
    • TABLE 50: Italian Viral Clearance Market Share Breakdown by Application: 2019 VS 2025
    • TABLE 51: Italian Demand for Viral Clearance in US$ Thousand by End-Use: 2018 to 2025
    • TABLE 52: Italian Viral Clearance Market Share Breakdown by End-Use: 2019 VS 2025
  • UNITED KINGDOM
    • TABLE 53: United Kingdom Demand Estimates and Forecasts for Viral Clearance in US$ Thousand by Application: 2018 to 2025
    • TABLE 54: Viral Clearance Market Share Shift in the United Kingdom by Application: 2019 VS 2025
    • TABLE 55: United Kingdom Demand Estimates and Forecasts for Viral Clearance in US$ Thousand by End-Use: 2018 to 2025
    • TABLE 56: Viral Clearance Market Share Shift in the United Kingdom by End-Use: 2019 VS 2025
  • REST OF EUROPE
    • TABLE 57: Rest of Europe Viral Clearance Addressable Market Opportunity in US$ Thousand by Application: 2018-2025
    • TABLE 58: Rest of Europe Viral Clearance Market Share Analysis by Application: 2019 VS 2025
    • TABLE 59: Rest of Europe Viral Clearance Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025
    • TABLE 60: Rest of Europe Viral Clearance Market Share Analysis by End-Use: 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 61: Viral Clearance Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2018-2025
    • TABLE 62: Asia-Pacific Viral Clearance Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025
    • TABLE 63: Viral Clearance Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2018-2025
    • TABLE 64: Asia-Pacific Viral Clearance Market Share Analysis: A 7-Year Perspective by End-Use for 2019 and 2025
  • REST OF WORLD
    • TABLE 65: Rest of World Viral Clearance Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025
    • TABLE 66: Rest of World Viral Clearance Market Share Analysis by Application: 2019 VS 2025
    • TABLE 67: Rest of World Viral Clearance Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2018 to 2025
    • TABLE 68: Rest of World Viral Clearance Market Share Analysis by End-Use: 2019 VS 2025

IV. COMPETITION

  • AVANCE BIOSCIENCES INC.
  • BSL BIOSERVICE SCIENTIFIC LABORATORIES MUNICH GMBH
  • CHARLES RIVER LABORATORIES INTERNATIONAL
  • CLEAN CELLS INC.
  • LONZA GROUP AG
  • MERCK KGAA
  • SGS SA
  • SIGMA-ALDRICH CORPORATION
  • TEXCELL, INC.

V. CURATED RESEARCH

Back to Top